Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes ; volume:32 ; number:1 ; day:20 ; month:12 ; year:2023 ; pages:1-11 ; date:1.2024
Supportive care in cancer ; 32, Heft 1 (20.12.2023), 1-11, 1.2024
- Creator
-
Mahfouz, Fawaz Mayez
Li, Tiffany
Joda, Masarra
Harrison, Michelle
Horvath, Lisa G.
Grimison, Peter
King, Tracy
Marx, Gavin
Goldstein, David
Park, Susanna B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-023-08245-w
- URN
-
urn:nbn:de:101:1-2024032721171749008128
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mahfouz, Fawaz Mayez
- Li, Tiffany
- Joda, Masarra
- Harrison, Michelle
- Horvath, Lisa G.
- Grimison, Peter
- King, Tracy
- Marx, Gavin
- Goldstein, David
- Park, Susanna B.
- SpringerLink (Online service)
Other Objects (12)
Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
Non-pharmacological therapy for chemotherapy-induced peripheral neurotoxicity: a network meta-analysis of randomized controlled trials
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper
Qualitative and quantitative assessment of peripheral neurotoxicity
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Correction to: Considerations for establishing and maintaining international research collaboration: the example of chemotherapy‑induced peripheral neurotoxicity (CIPN)—a white paper
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Examination of microcystin neurotoxicity using central and peripheral human neurons
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
Non-pharmacological therapy for chemotherapy-induced peripheral neurotoxicity: a network meta-analysis of randomized controlled trials
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper
Qualitative and quantitative assessment of peripheral neurotoxicity
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Correction to: Considerations for establishing and maintaining international research collaboration: the example of chemotherapy‑induced peripheral neurotoxicity (CIPN)—a white paper
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Examination of microcystin neurotoxicity using central and peripheral human neurons
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
Non-pharmacological therapy for chemotherapy-induced peripheral neurotoxicity: a network meta-analysis of randomized controlled trials
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper
Qualitative and quantitative assessment of peripheral neurotoxicity
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Correction to: Considerations for establishing and maintaining international research collaboration: the example of chemotherapy‑induced peripheral neurotoxicity (CIPN)—a white paper
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Examination of microcystin neurotoxicity using central and peripheral human neurons